TipRanks
Go Ultimate75% OFF

Kevin Kometer Insider Profile

4 Followers

Kevin Kometer, Sr MD Chief Information Office at CME Group, holds 63.21K shares in CME Group (Ticker: CME). Most recently, Kevin Kometer Sold 13,500 shares of CME Group on Feb 14, 2022 for an estimated value of $3.29M.

Kevin Kometer's Trading History

CME
CME Group
Feb 14, 2022Sr MD Chief Information OfficeInformative Sell3.29M$19.33M
CME
Insider Shares: 63.21K (0.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 14, 2022Informative Sell$3.29M13,500$244.03+18.30%
Sep 17, 2021Uninformative Sell$66.42K352$188.69―
Sep 16, 2021Uninformative Sell$253.73K1,343$188.92―
Sep 16, 2021Uninformative Buy$0.003,968$0.00―
Mar 17, 2021Uninformative Sell$713.83K3,414$209.09―

You May Also Like

Kevin Kometer insider profile FAQ

What is the percentage of profitable transactions made by Kevin Kometer?
The percentage of profitable transactions made by Kevin Kometer is 25%.
What is the average return per transaction made by Kevin Kometer?
The average return per transaction made by Kevin Kometer is -17.80%.
What stocks does Kevin Kometer hold?
Kevin Kometer holds: CME stocks.
What was Kevin Kometer’s latest transaction?
Kevin Kometer’s latest transaction was an Informative Sell of $3.29M.
What was Kevin Kometer's most profitable transaction?
Kevin Kometer’s most profitable transaction was an Informative Sell of CME stock on February 14, 2022. The return on the trade was 18.30%.
What is Kevin Kometer's role in CME Group?
Kevin Kometer's role in CME Group is Sr MD Chief Information Office.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.